Cardiogenic shock (CS) is a complex multifactorial clinical syndrome with extremely high
mortality, developing as a continuum, and progressing from the initial insult (underlying …

Cardiogenic shock can occur due to acute ischaemic or non-ischaemic cardiac events, or
from progression of long-standing underlying heart disease. When addressing the cause of …

Background The effects of temporary mechanical circulatory support with a microaxial flow
pump on mortality among patients with ST-segment elevation myocardial infarction (STEMI) …

Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is
increasingly being used for circulatory support in patients with cardiogenic shock, although …

The use of temporary mechanical circulatory support in cardiogenic shock has increased
dramatically despite a lack of randomized controlled trials or evidence guiding clinical …

Importance Acute myocardial infarction (AMI) complicated by cardiogenic shock is
associated with substantial morbidity and mortality. Although intravascular microaxial left …

Cardiogenic shock (CS) remains the most common cause of mortality in patients with acute
myocardial infarction. The SHOCK trial (Should We Emergently Revascularize Occluded …

Background In acute myocardial infarction complicated by cardiogenic shock the use of
mechanical circulatory support devices remains controversial and data from randomized …

Abstract Background The Society of Cardiovascular Angiography and Interventions (SCAI)
have recently proposed a new classification of cardiogenic shock (CS) dividing patients into …

There has been a significant increase in the use of short-term percutaneous ventricular
assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide …